Summary
Medtronic plc filed an 8-K on May 22, 2024, to announce its full-year and fourth-quarter fiscal year 2024 financial results. This filing primarily serves to attach the official press release detailing these results, which was issued on May 23, 2024. Investors should refer to the press release (Exhibit 99.1) for specific financial performance data, including revenue, profit margins, earnings per share, and guidance for the upcoming fiscal year. The 8-K itself does not contain the detailed financial figures but directs stakeholders to the comprehensive information provided in the accompanying press release.
Key Highlights
- 1Medtronic announced its full-year and fourth-quarter fiscal year 2024 financial results on May 23, 2024.
- 2The 8-K filing officially furnishes the press release containing these financial results as Exhibit 99.1.
- 3Investors need to consult the provided press release for detailed financial performance and operational data.
- 4The filing indicates the reporting period covers the full fiscal year 2024 and the fourth quarter of fiscal year 2024.
- 5The event date for the announcement of results was May 22, 2024, with the filing occurring on the same day.
- 6The press release contains forward-looking statements and guidance, which are crucial for investor outlook.